• Featured News

    In case you missed it: This week’s Top 5 stories on social media

Check out a few of the most popular News Network stories on @mayoclinic social media this past week.

Study documents safety, improvements from stem cell therapy after spinal cord injury

A recent Mayo Clinic study indicates that stem cells obtained from the fat tissue of patients are both safe and could enhance sensation and movement following traumatic spinal cord injuries. These findings provide valuable insights into the potential of cell therapy for people dealing with spinal cord injuries and paralysis, especially when options to enhance functionality are severely restricted.

Mayo Clinic Minute: 3 ways to prevent head and neck cancer

Throat cancer, often associated with HPV, is one of the fastest-growing cancers. According to Dr. Katharine Price, a Mayo Clinic medical oncologist, there are three strategies to lower your risk and potentially prevent head and neck cancer.

Mayo Clinic Minute: What is a living donor chain?

A person is added to the national kidney transplant waiting list every 10 minutes. To increase the pool of organs available for transplant, living kidney donor chains are a promising solution. Dr. Shennen Mao, a Mayo Clinic transplant surgeon, explains how donor chains work.

Untangling the threads of early onset dementia

Frontotemporal dementia (FTD) can be extremely debilitating, leading to changes in personality, behavior and language. Mayo Clinic researchers have focused on understanding how various forms of a protein linked to FTD can influence the risk and severity of the disease.

New study finds triple-negative breast cancer tumors with an increase in immune cells have lower risk of recurrence after surgery

A new study suggests that people who have early-stage triple-negative breast cancer and high levels of immune cells, also known as tumor-infiltrating lymphocytes, or TILs, within their tumors may have a lower risk of recurrence and better survival rates even when not treated with chemotherapy.